Vanguard Personalized Indexing Management LLC Has $821,000 Holdings in Align Technology, Inc. $ALGN

Vanguard Personalized Indexing Management LLC trimmed its stake in Align Technology, Inc. (NASDAQ:ALGN) by 49.5% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 6,554 shares of the medical equipment provider’s stock after selling 6,417 shares during the period. Vanguard Personalized Indexing Management LLC’s holdings in Align Technology were worth $821,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Rothschild Investment LLC grew its position in shares of Align Technology by 140.3% in the 2nd quarter. Rothschild Investment LLC now owns 149 shares of the medical equipment provider’s stock valued at $28,000 after buying an additional 87 shares during the last quarter. True Wealth Design LLC lifted its stake in shares of Align Technology by 7,650.0% in the second quarter. True Wealth Design LLC now owns 155 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 153 shares during the period. CYBER HORNET ETFs LLC bought a new stake in Align Technology in the second quarter valued at approximately $36,000. MUFG Securities EMEA plc acquired a new stake in Align Technology during the 2nd quarter valued at approximately $38,000. Finally, Steigerwald Gordon & Koch Inc. bought a new position in Align Technology during the 3rd quarter worth approximately $26,000. 88.43% of the stock is owned by institutional investors.

Align Technology Trading Down 4.0%

Shares of NASDAQ ALGN opened at $157.05 on Wednesday. The firm has a market capitalization of $11.27 billion, a P/E ratio of 30.44, a P/E/G ratio of 1.84 and a beta of 1.84. The firm’s 50-day moving average price is $161.60 and its 200-day moving average price is $148.50. Align Technology, Inc. has a 1-year low of $122.00 and a 1-year high of $232.20.

Wall Street Analyst Weigh In

ALGN has been the topic of a number of analyst reports. Wall Street Zen raised shares of Align Technology from a “hold” rating to a “buy” rating in a research note on Saturday, January 3rd. Jefferies Financial Group upped their price target on shares of Align Technology from $140.00 to $155.00 in a research report on Thursday, October 30th. Leerink Partners increased their price target on Align Technology from $189.00 to $210.00 and gave the stock an “outperform” rating in a report on Thursday, January 22nd. UBS Group dropped their price objective on Align Technology from $160.00 to $155.00 and set a “neutral” rating on the stock in a research note on Thursday, October 16th. Finally, Needham & Company LLC restated a “hold” rating on shares of Align Technology in a research report on Thursday, October 30th. Six investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat.com, Align Technology presently has a consensus rating of “Hold” and a consensus target price of $176.82.

About Align Technology

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.